neurology
-
anti-CD20 therapy, Brain, cladribine, Delphi consensus, disease modifying therapy, high efficacy DMTs, multiple sclerosis, Neurodegenerative Diseases, neurology, neuroscience, patient involvement, personalized therapy, treatment adherenceMultiple Sclerosis Personalized Therapy: 70% Delphi Consensus
An Italian multiple sclerosis Delphi panel reached consensus on 116 of 166…
-
exenatide, GLP-1, lixisenatide, network meta-analysis, Neurodegenerative Diseases, neurology, neuroprotection, neuroscience, Ozempic, parkinson’s diseaseCan GLP-1 Drugs Slow Parkinson’s Disease? Evidence from 5 Trials
Research Highlights GLP-1 receptor agonists are diabetes drugs (Ozempic, Trulicity, Byetta) being…
